Related Experiment Videos

Dose-response study of oral fenoterol in asthmatic children

Developmental Pharmacology and Therapeutics
|January 1, 1980
PubMed

Insights

This study found that 5 mg of oral fenoterol (a beta 2-receptor stimulant) optimally improved bronchodilation in children with minimal side effects. Higher doses did not significantly increase benefits but maintained low side effect profiles.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Beta 2-receptor stimulants are crucial for managing pediatric respiratory conditions.
  • Determining optimal dosing balances efficacy and safety in children.

Purpose of the Study:

  • To identify the optimal dose of oral fenoterol for bronchodilation in children.
  • To evaluate the dose-response relationship for fenoterol's efficacy and side effects.

Main Methods:

  • A double-blind, placebo-controlled crossover study involving 12 children.
  • Comparison of three fenoterol doses (2.5, 5, 7.5 mg) and placebo over 3 hours.
  • Assessment of ventilatory function, pulse rate, blood pressure, and clinical signs.

Main Results:

  • Fenoterol demonstrated significant bronchodilation, peaking at 60-90 minutes.
  • The 5 mg and 7.5 mg doses provided maximal bronchodilation, with no significant difference between them.
  • Minimal side effects were observed across all tested doses, with no clear dose-response for cardiovascular effects.

Conclusions:

  • 5 mg of oral fenoterol offers an optimal balance of bronchodilatory effect and minimal side effects in pediatric patients.
  • Fenoterol is a safe and effective bronchodilator for children, with 5 mg being a recommended dose.

Related Concept Videos